430 related articles for article (PubMed ID: 427806)
21. Changes in distribution of human malignant melanoma membrane antigens in the presence of human antibody by immunofluorescence.
Leong SP; Sutherland CM; Krementz ET
Cancer Res; 1977 Jan; 37(1):293-8. PubMed ID: 318607
[TBL] [Abstract][Full Text] [Related]
22. Increased immunogenicity of tumor vaccines complexed with anti-Gal: studies in knockout mice for alpha1,3galactosyltransferase.
LaTemple DC; Abrams JT; Zhang SY; Galili U
Cancer Res; 1999 Jul; 59(14):3417-23. PubMed ID: 10416604
[TBL] [Abstract][Full Text] [Related]
23. Human monoclonal antibody to tumor-associated ganglioside GD2.
Katano M; Saxton RE; Irie RF
J Clin Lab Immunol; 1984 Nov; 15(3):119-26. PubMed ID: 6099419
[TBL] [Abstract][Full Text] [Related]
24. Isolation of human tumor-specific antibodies by selection of an antibody phage library on melanoma cells.
Kupsch JM; Tidman NH; Kang NV; Truman H; Hamilton S; Patel N; Newton Bishop JA; Leigh IM; Crowe JS
Clin Cancer Res; 1999 Apr; 5(4):925-31. PubMed ID: 10213230
[TBL] [Abstract][Full Text] [Related]
25. Autologous antibodies eluted from membrane fragments in human ovarian epithelial neoplastic effusions. II. Tissue specificity and reactivity.
Kutteh WH; Doellgast GJ
J Natl Cancer Inst; 1986 May; 76(5):797-804. PubMed ID: 3517453
[TBL] [Abstract][Full Text] [Related]
26. Clinical and immunological significance of human melanoma cytotoxic antibody.
Bodurtha AJ; Chee DO; Laucius JF; Mastrangelo MJ; Prehn RT
Cancer Res; 1975 Jan; 35(1):189-93. PubMed ID: 1109788
[TBL] [Abstract][Full Text] [Related]
27. Human melanoma and leukemia associated antigens difined by nonhuman primate antisera.
Seigler HF; Metzgar RS; Mohanakumar T; Stuhlmiller GM
Fed Proc; 1975 Jul; 34(8):1642-6. PubMed ID: 805717
[TBL] [Abstract][Full Text] [Related]
28. "Hidden" cytotoxic antibodies that react with allogeneic cultured fetal and tumor cells contained in soluble immune complexes from normal human sera.
Morgan AC; Rossen RD; McCormick KJ; Stehlin JS; Giovanella BC
Cancer Res; 1982 Mar; 42(3):881-7. PubMed ID: 7059986
[TBL] [Abstract][Full Text] [Related]
29. Cellular immune response to human sarcomas: cytotoxic T cell clones reactive with autologous sarcomas. I. Development, phenotype, and specificity.
Slovin SF; Lackman RD; Ferrone S; Kiely PE; Mastrangelo MJ
J Immunol; 1986 Nov; 137(9):3042-8. PubMed ID: 3093588
[TBL] [Abstract][Full Text] [Related]
30. Production of antisera with specificity for malignant melanoma and human fetal skin.
Fritze D; Kern DH; Drogemuller CR; Pilch YH
Cancer Res; 1976 Feb; 36(2 Pt 1):458-66. PubMed ID: 56991
[TBL] [Abstract][Full Text] [Related]
31. Prolonged survival for melanoma patients with elevated IgM antibody to oncofetal antigen.
Jones PC; Sze LL; Liu PY; Morton DL; Irie RF
J Natl Cancer Inst; 1981 Feb; 66(2):249-54. PubMed ID: 6935475
[TBL] [Abstract][Full Text] [Related]
32. Monoclonal antibody identification and characterization of two human sarcoma-associated antigens.
Stastny JJ; Brown JM; Beattie CW; Das Gupta TK
Cancer Res; 1991 Jul; 51(14):3768-73. PubMed ID: 2065331
[TBL] [Abstract][Full Text] [Related]
33. Antigens on human tumor cells assayed by complement fixation with allogeneic sera.
Gupta RK; Irie RF; Morton DL
Cancer Res; 1978 Aug; 38(8):2573-80. PubMed ID: 78763
[No Abstract] [Full Text] [Related]
34. Inhibition of antibody-complement-mediated killing of tumor cells by hormones.
Schlager SI; Ohanian SH; Borsos T
Cancer Res; 1976 Oct; 36(10):3672-7. PubMed ID: 182362
[TBL] [Abstract][Full Text] [Related]
35. Screening human antibody libraries against carcinoma cells by affinity purification and polymerase chain reaction.
Reiersen H; Berntsen G; Stassar M; Cochlovius B
J Immunol Methods; 2008 Jan; 330(1-2):44-56. PubMed ID: 18082761
[TBL] [Abstract][Full Text] [Related]
36. Antibody-dependent cell-mediated cytolysis of human colon carcinoma cells induced by specific antisera against carcinoembryonic antigen.
Carrel S; Delisle MC; Mach JP
Cancer Res; 1977 Aug; 37(8 Pt 1):2644-50. PubMed ID: 872092
[TBL] [Abstract][Full Text] [Related]
37. Indirect rosette microassay to characterize human melanoma-associated antigens recognized by operationally specific xenoantisera.
Imai K; Ferrone S
Cancer Res; 1980 Jul; 40(7):2252-6. PubMed ID: 6966965
[TBL] [Abstract][Full Text] [Related]
38. Common expression of melanoma tumor-associated antigens recognized by human tumor infiltrating lymphocytes: analysis by human lymphocyte antigen restriction.
Hom SS; Topalian SL; Simonis T; Mancini M; Rosenberg SA
J Immunother (1991); 1991 Jun; 10(3):153-64. PubMed ID: 1868040
[TBL] [Abstract][Full Text] [Related]
39. [Vaccine therapy of malignant melanoma. II. Serological evaluation of the immune responses to the injection using allogeneic melanoma cell vaccine].
Takeyama H; Watanabe T; Livingston PO
Gan To Kagaku Ryoho; 1983 Jul; 10(7):1624-33. PubMed ID: 6870307
[TBL] [Abstract][Full Text] [Related]
40. Immunological block to synthetic alpha-melanocyte-stimulating hormone: melanocyte interaction by antibodies isolated from cell-column immunoadsorbents.
Winkelhake JL; Elcombe BM; Hodach A
Cancer Res; 1979 Aug; 39(8):3058-64. PubMed ID: 455290
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
